Search

You searched for "VUR"

378 results found

Long-term oncologic outcomes of salvage cryoablation for rrPC

1 July 2017 | | Urologic Oncology
Of patients undergoing radiotherapy (RT) for prostate cancer (PC), at least 15-20% will experience recurrence. Although salvage prostatectomy achieves durable oncological outcomes at 10 years, it is associated with significantly high morbidity. Thus, the majority of men with radio-recurrent prostate...

Prilocaine irrigation for pain relief after TURP

1 March 2014 | | Endourology and Stones
Transurethral resection of the prostate (TURP) is one of the commonest procedures undertaken by urologists. There are well known complications following the procedure which commonly include haematuria but also TUR syndrome, failure to pass urine and infections, amongst others. The...

Demanding cases or nightmares in endourology? Jan/Feb 2016

1 January 2016 | | Endourology and Stones
The second article in this series of challenging cases in endourology describes some stent-related problems. Case 1 A 76-year-old male with end stage renal failure due to obstructive uropathy from benign prostatic enlargement was transferred from a referring hospital. A...

Lasers in benign prostatic hyperplasia

1 January 2014 | | Functional Urology, Technological Developments
Clinical benign prostatic hyperplasia (BPH) impacts on the quality of life of many men. It is intimately related to ageing, but exact calculations of its prevalence remain difficult since an accurate clinical definition still eludes us. Histological BPH has been...

Benign prostatic hyperplasia: what are the benefits and harms of various surgical management options?

9 March 2020 | | Functional Urology, Infection, Neurourology, Technological Developments
Benign prostatic hyperplasia (BPH) is characterised by stromal and epithelial prostatic cell hyperplasia. The enlarged prostate may be associated with voiding and storage lower urinary tract symptoms (LUTS). These have been predominantly attributed to bladder outlet obstruction (BOO), assumed to...

The medical management of LUTS/BPH – an update

1 July 2018 | | Functional Urology
For many years it has been recognised by both medical professionals and the general public that the development of lower urinary tract symptoms (LUTS) is highly prevalent and is predominantly age-dependent. Medical professionals understand that in men this is often,...

Blaedderwaerc and other names

1 July 2016 | | Infection, Functional Urology, Technological Developments
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I said I would explore the history of something...

Balanitis xerotica obliterans

1 September 2018 | | Andrology, Urologic Oncology
Balanitis xerotica obliterans (BXO) / lichen sclerosus of the male genitalia is a common cause of acquired phimosis, and was first described by Stuhmer in 1928 [1]. It is described in medical literature as a chronic inflammatory condition of unknown...

Demanding cases or nightmares in endourology? Sep/Oct 2016

1 September 2016 | | Endourology and Stones
In this issue the authors will present once in a career cases that can truly haunt a urologist. “Mistakes are like bad loves, the more you learn from them, the more you wish they’d never happened. “ Gregory David Roberts*...

The role of conservative renal colic treatment

1 January 2018 | | Endourology and Stones, Trauma and Emergency Urology
Acute renal colic is a common emergency condition, which can arise from a variety of underlying conditions that affect the urinary tract, but it is usually associated with the passage of ureteral stones. Before considering expectant management or active intervention,...

Testing radical prostatectomy in men with prostate cancer and oligometastases to the bone: a randomised controlled feasibility study

1 May 2017 | | Urologic Oncology
Prostate cancer is the commonest cancer and the second most frequent cause of cancer death in Western men [1]. The recent STAMPEDE data suggests a median survival of just 42.1 months in the control arm of metastatic men [2]. Current...

Demanding cases or nightmares in uro-oncology? Sep/Oct 2022

5 September 2022 | | Urologic Oncology
Treatment of prostate cancer in renal transplant recipients is challenging due to a lack of knowledge of the natural history of cancer in these patients, the anatomical position of the graft in the iliac fossa and its proximity to the...